October 22, 2024--(BUSINESS WIRE)--Science Corporation, a leader in brain-computer interface ("BCI") technology, has announced the preliminary clinical trials results for its PRIMA retina implant.
The first poster demonstrates proof-of-concept data that Aqtual's therapy selection test can predict treatment response in patients with RA. The second poster provides an interim analysis from ...
GlobalData on MSN26d
Science Corp brain implant restores patient vision in preliminary trialsUS-based brain-computer interface company, Science Corporation, has announced preliminary results from the trial of its PRIMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback